Finance

Beta
Lists
SANA:NASDAQ
Sana Biotechnology Inc
$2.68
-9.46%
(-0.28) 1D
$2.71
+1.12% (+0.030)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SANA...
Open
$2.93
High
$2.95
Low
$2.66
Mkt. cap
745.82M
Avg. vol.
3.85M
Volume
4.68M
52-wk high
$6.55
52-wk low
$2.43
EPS
-$0.94
Beta
2.14
Shares outstanding
278.29M
No. of employees
142
Open
$2.93
High
$2.95
Low
$2.66
Mkt. cap
745.82M
Avg. vol.
3.85M
Volume
4.68M
52-wk high
$6.55
52-wk low
$2.43
EPS
-$0.94
Beta
2.14
Shares outstanding
278.29M
No. of employees
142
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to SANA in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SANA in the last 3 months.
Highest
Current $2.68
$16.00 (+497.01%)
Average
$9.80 (+265.67%)
Lowest
$7.00 (+161.19%)
News stories
From sources across the web
About Sana Biotechnology Inc
CEOSteve Harr
Employees142
Founded2018
Headquarters-
SectorBiotechnology
Websitesana.com
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.14 / -$0.15
+4.55%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
33.72M
35.22M
40.44M
26.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.34M
10.28M
12.19M
11.46M
Operating expense
44.06M
45.51M
52.62M
37.87M
Total operating expenses
44.06M
45.51M
52.62M
37.87M
Operating income
-44.06M
-45.51M
-52.62M
-37.87M
Other non operating income
598.00K
360.00K
3.40M
453.00K
EBT including unusual items
-93.80M
-42.15M
-58.82M
-47.21M
EBT excluding unusual items
-42.89M
-44.14M
-47.95M
-36.46M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-93.80M
-42.15M
-58.82M
-47.21M
Net profit margin
-
-
-
-
Earnings per share
-0.16
-0.15
-0.16
-0.14
Interest and investment income
577.00K
1.00M
1.28M
951.00K
Interest expense
-
-
-
-
Net interest expenses
577.00K
1.00M
1.28M
951.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-41.21M
-42.32M
-49.57M
-35.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more